Menstrual blood-derived endometrial stem cells ameliorate the viability of ovarian granulosa cells injured by cisplatin through activating autophagy.

导出 LinkOut

翻译打印收藏纠错

作者： Xiaofei,Fu ^[1] ; Shenghui,Zhang ^[2] ; Tingting,Li ^[3] ; Ruiyun,Zhang ^[2] ; Yilin,Lu ^[2] ; Hongbin,Cheng ^[4] ; Yanhua,Xu ^[5] ; Haixia,Qin ^[6] ; Yanli,Liu ^[7] ; Juntang,Lin ^[4]

作者单位： Stem Cell andCerapy Technology Research Center, College of Life Science and Technology, Xinxiang Medical University, Xinxiang 453003, China; The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China. ^[1] Stem Cell andCerapy Technology Research Center, College of Life Science and Technology, Xinxiang Medical University, Xinxiang 453003, China. ^[2] The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China. ^[3] Stem Cell andCerapy Technology Research Center, College of Life Science and Technology, Xinxiang Medical University, Xinxiang 453003, China; College of Biomedical Engineering, Xinxiang Medical University, Xinxiang 453003, China; The Third Medical Center of Chinese PLA General Hospital, Beijing 100039, China. ^[4] The Second People's Hospital of Hebi, Hebi 458031, China. ^[5] The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453100, China. Electronic address: 1982584896@qq.com. ^[6] Stem Cell andCerapy Technology Research Center, College of Life Science and Technology, Xinxiang Medical University, Xinxiang 453003, China. Electronic address: liuyanli198512@163.com. ^[7]

关键词 Chemotherapy Female fertility Menstrual blood-derived endometrial stem cells Ovarian granulosa cells Ovarian injury